Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal keratins are intermediate filament proteins highly expressed in the outermost layers of skin and related epithelia. Their function and mechanical stability depend on the formation of intermolecular disulfide bonds between cysteine residues, particularly prominent during terminal differentiation and in structures such as the stratum corneum of the epidermis and hair shafts. These disulfide linkages—formed both enzymatically and under oxidative conditions—are crucial for the assembly, elongation limits, and organization of keratin filaments, and for establishing a resilient cell and tissue architecture. Abnormal keratin structure due to defective disulfide bonding or keratin gene mutations can result in skin and hair diseases, while cosmetic procedures often target these bonds to alter hair shape. However, "epidermal keratin/protein disulfide bonds" is a structural concept rather than a unitary molecular target.
For cosmetic interventions: chemical breakage or reformation of disulfide bonds to alter hair structure. No established pharmacological mechanisms for therapeutic agents specifically targeting this feature in disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal Keratin Disulfide Bonds (Biochemical Feature) (N/A).